.Attributes Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view calls for inclusion of clients with MASLD and also measurement of liver results in cardio-- renal-- metabolic tests, when records recommend mechanistically possible benefits as well as clinical safety and security-- and summarizes points to consider for test design as well as regulatory approval.